The AngioVac® is a vacuum-assisted percutaneous thrombectomy suction system. In critically ill patients, the sudden volume shift can result in abrupt hemodynamic changes thus leading to a cardiac right-left shunt with a high risk of paradoxical embolization. We describe a modified cardiopulmonary bypass circuit for the use of the AngioVac® system that enables full cardiopulmonary support and reduces paradoxical thromboembolic risk.
TeunissenPFATijssenRvan MontfoortML, et al. Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention. Thromb Res2016; 137: 64–71, http://www.ncbi.nlm.nih.gov/pubmed/26654718
2.
HameedILauCKhanFM, et al. AngioVac for extraction of venous thromboses and endocardial vegetations: a meta-analysis. J Card Surg2019; 34: 170–180, http://www.ncbi.nlm.nih.gov/pubmed/30843269
3.
WorkuBSalemiADʼAyalaMD, et al. The AngioVac device: understanding the failures on the road to success. Innovations (Phila)2016; 11: 430–433, http://www.ncbi.nlm.nih.gov/pubmed/27879533
4.
MichelsonCMDykeCMWickDJ, et al. Use of a modified cardiopulmonary bypass circuit for suction embolectomy with the AngioVac device. J Extra Corpor Technol2017; 49: 299–303.
5.
RayHMAl RstumZSaqibNU.Successful cerebral protection during removal of large right atrial thrombus with AngioVac in a patient with patent foramen ovale and recent embolic stroke. J Vasc Surg Cases Innov Tech2019; 5: 201–204, http://www.ncbi.nlm.nih.gov/pubmed/31289763
